SSC
IMGN

Syverson Strege & Co’s Immunogen Inc IMGN Stock Holding History

Syverson Strege & Co’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-42
Closed -$161 – 657
2023
Q1 		$161 Hold
42
– – ﹤0.01% 658
2022
Q4 		$208 Hold
42
– – ﹤0.01% 308
2022
Q3 		$0 Hold
42
– – ﹤0.01% 343
2022
Q2 		$0 Hold
42
– – ﹤0.01% 352
2022
Q1 		$0 Hold
42
– – ﹤0.01% 337
2021
Q4 		$0 Hold
42
– – ﹤0.01% 494
2021
Q3 		$0 Hold
42
– – ﹤0.01% 478
2021
Q2 		$0 Hold
42
– – ﹤0.01% 298
2021
Q1 		$0 Hold
42
– – ﹤0.01% 288
2020
Q4 		$0 Buy
+42
New +$245 ﹤0.01% 257

Other funds holding IMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Syverson Strege & Co's IMGN Position: Q2 2023 in Review

Syverson Strege & Co sold out of Immunogen Inc (IMGN) in Q2 2023, closing a stake of 42 shares — an estimated $161 sold.

Syverson Strege & Co first reported a position in IMGN in Q4 2020 and held it in 10 quarters. The position peaked at $208 in Q4 2022. 266 funds tracked by Wall St. Rank hold IMGN as of Q2 2023.

  • Syverson Strege & Co reported no remaining Immunogen Inc position as of Q2 2023 after selling out during the quarter.
  • Syverson Strege & Co sold 42 Immunogen Inc shares in Q2 2023, an estimated $161.
  • Syverson Strege & Co first reported a position in Immunogen Inc in Q4 2020 and held it in 10 quarters.
  • Syverson Strege & Co's Immunogen Inc position peaked at $208 in Q4 2022.
  • 266 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2023.

Based on Syverson Strege & Co's 13F filing for Q2 2023, filed 4 Aug 2023.